Promising Emerging Classes of Therapies in Non-Small Cell Lung Cancer
14 意见
• 07/14/23
0
0
嵌入
David Gandara, MD, Corey J. Langer, MD, Anne S. Tsao, MD, Alan B. Sandler, MD, and Mark A. Socinski, MD, each provide their opinion on the most promising emerging class of therapeutics in non-small cell lung cancer (NSCLC).
More from this Peer Exchange discussion: http://www.onclive.com/peer-ex....change/nsclc-advance
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论